Core Laboratories (CLB) Total Debt (2022 - 2026)

Core Laboratories' Total Debt history runs 5 years deep, the most recent figure standing at $114.5 million for Q1 2026.

• On a quarterly basis, Total Debt fell 7.97% year-over-year to $114.5 million in Q1 2026; TTM through Mar 2026 was $114.5 million, a 7.97% decrease from a year earlier, with the FY2025 full-year figure at $110.3 million, down 12.57% from the prior year.
• Total Debt advanced to $114.5 million in Q1 2026 per CLB's latest filing, from $110.3 million in the prior quarter.
• Across five years, Total Debt topped out at $182.6 million in Q2 2023 and bottomed at $110.3 million in Q4 2025.
• The 5-year median for Total Debt is $139.9 million (2024), against an average of $142.9 million.
• Across the five-year window, Total Debt dropped 5.37% in 2023 and slipped 22.69% in 2024, its largest moves.
• Year by year, Total Debt stood at $172.4 million in 2022, then dropped by 5.37% to $163.1 million in 2023, then dropped by 22.69% to $126.1 million in 2024, then decreased by 12.57% to $110.3 million in 2025, then increased by 3.81% to $114.5 million in 2026.
• Per Business Quant, the three latest CLB Total Debt figures stand at $114.5 million (Q1 2026), $110.3 million (Q4 2025), and $114.1 million (Q3 2025).